🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alberto D’Angelo

Royal United Hospital

ORCID: 0000-0001-8417-9172

Also affiliated with Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies.

105 citations

Navid Sobhani, Robert Chapman, Stefan Bagby, Carlotta Bortoletti, Mirko Traversini +5 more

19 citations

Irene De Gennaro, Ismaela Vascotto, Giulia Venturi, Alberto D’Angelo, Costanza Winchler +13 more

N/A
0.385DataRank · unranked
12 citations

Navid Sobhani, Stefan Bagby, Andrea Casadei-Gardini, Giandomenico Roviello, Alberto D’Angelo